Research map: Germline genetic risk and prostate cancer–specific mortality in a population-based incident cohort

Back to the article

Papers in this map

  1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Sue M. Richards · 2015 · 33500 citations · Cited by this paper
  2. GenProb‐PCSM: A Simplified Weighted Germline Score for Prostate Cancer‐Specific Mortality · Jun Wei · 2026 · Cites this paper
  3. Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study · 2026 · Related
  4. The UK Biobank resource with deep phenotyping and genomic data · Clare Bycroft · 2018 · 10126 citations · Cited by this paper
  5. Robot-assisted MRI/US transperineal target prostate biopsy with Biobot Mona Lisa 2.0: first experience in Europe · 2026 · Related
  6. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer · Colin C. Pritchard · 2016 · 1704 citations · Cited by this paper
  7. Systematic profiling of tumor-associated antigen expression for antibody-drug conjugate in prostate cancer · 2025 · Related
  8. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines · Quan Li · 2017 · 1120 citations · Cited by this paper
  9. Persistence, progression, and PSA: what exactly does DEAR-EXT compare? · 2026 · Related
  10. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer · Freddie Charles Hamdy · 2023 · 819 citations · Cited by this paper
  11. Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates · 2026 · Related
  12. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation · Samuel A. Lambert · 2021 · 775 citations · Cited by this paper
  13. Prostate biopsy - current discussions and future perspectives · 2026 · Related
  14. Prostate cancer · Shahneen Kaur Sandhu · 2021 · 590 citations · Cited by this paper
  15. Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care · 2026 · Related
  16. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction · David V. Conti · 2021 · 511 citations · Cited by this paper
  17. Navigating drug–drug interactions with apalutamide · 2026 · Related
  18. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death · Rong Na · 2016 · 348 citations · Cited by this paper
  19. Efficacy of the new P100 extracorporeal shock wave therapy device in the treatment of type IIIB chronic prostatitis/chronic pelvic pain syndrome: a sham treatment controlled, prospective clinical trial · 2026 · Related
  20. Prostate Cancer · Ruben Raychaudhuri · 2025 · 345 citations · Cited by this paper
  21. Prostate Cancer, Version 3.2024 · Edward Matthew Schaeffer · 2024 · 302 citations · Cited by this paper
  22. Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer · H. Ballentine Carter · 2018 · 215 citations · Cited by this paper
  23. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer · Felix Yi-Chung Feng · 2021 · 157 citations · Cited by this paper
  24. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate · Robert Timothy Dess · 2020 · 94 citations · Cited by this paper
  25. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer · Burcu F. Darst · 2020 · 90 citations · Cited by this paper
  26. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study · Vincent J. Gnanapragasam · 2016 · 89 citations · Cited by this paper
  27. HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer · Jason W.D. Hearn · 2020 · 77 citations · Cited by this paper
  28. Genome Sequencing during a Patient’s Journey through Cancer · Jyoti Nangalia · 2019 · 71 citations · Cited by this paper
  29. Cause of death during prostate cancer survivorship: A contemporary, US population–based analysis · Adam Benjamin Weiner · 2021 · 70 citations · Cited by this paper
  30. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer · Yishuo Wu · 2020 · 57 citations · Cited by this paper
  31. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer · Burcu F. Darst · 2023 · 57 citations · Cited by this paper
  32. HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond · Navin Sabharwal · 2019 · 52 citations · Cited by this paper
  33. HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies · Daniel Joseph Khalaf · 2020 · 45 citations · Cited by this paper
  34. Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype · Changxue Lu · 2020 · 43 citations · Cited by this paper
  35. Elevated MRE11 expression associated with progression and poor outcome in prostate cancer · Jun Wang · 2019 · 28 citations · Cited by this paper
  36. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry · Burcu F. Darst · 2023 · 28 citations · Cited by this paper
  37. Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank · Jiaqi Hu · 2024 · 18 citations · Cited by this paper
  38. A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer · Srilakshmi Srinivasan · 2024 · 16 citations · Cited by this paper
  39. Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases · Jonathan Mitchell · 2025 · 16 citations · Cited by this paper

Source: OpenAlex (CC0)